The content on this page is designed for Australia. Check courses designed for Canada (EN)

This course has expired. View available courses.

Infectious Disease

Eliminating Hepatitis C by 2030: what’s stigma got to do with it? (ACRRM)

Hepatitis C virus (HCV) is a potentially life-threatening virus that primarily affects the liver. In Australia, over 170,000 people were estimated to have chronic HCV infection at the start of 2017 and 130,000 were still living with HCV at the end of 2018. The introduction of direct-acting antiviral (DAA) therapies, which can cure HCV in the majority of patients, represents a major advance and all Australians living with HCV should now be considered for DAA therapy. However, stigma represents a key barrier to diagnosis and treatment. As a result, Australia’s Fifth National Hepatitis C Strategy 2018–2022 has identified stigma and discrimination as one of five key priority areas for action.


This program is supported by an independent educational grant provided by Gilead sciences.

DURATION

1.5 hr

PROFESSION

Physician

# OF CREDITS

1

ACCREDITATION

ACRRM

EXPIRY DATE

2022-12-31

Hepatitis C virus (HCV) is a potentially life-threatening virus that primarily affects the liver. In Australia, over 170,000 people were estimated to have chronic HCV infection at the start of 2017 and 130,000 were still living with HCV at the end of 2018. The introduction of direct-acting antiviral (DAA) therapies, which can cure HCV in the majority of patients, represents a major advance and all Australians living with HCV should now be considered for DAA therapy. However, stigma represents a key barrier to diagnosis and treatment. As a result, Australia’s Fifth National Hepatitis C Strategy 2018–2022 has identified stigma and discrimination as one of five key priority areas for action.


This program is supported by an independent educational grant provided by Gilead sciences.

Faculty

Prof Carla Treloar, Director of the Centre for Social Research in Health and the Social Policy Research Centre, UNSW

Dr Anne Balcomb, GP, Orange

Dr David Baker, GP, Sydney

Learning objectives

On completion of this program, participants will be better able to:

  • Recognise the different ways in which stigma related to hepatitis C virus (HCV) infection can present in the primary care setting
  • Describe the ways in which stigma can have a negative impact on outcomes for patients with HCV infection
  • Understand the ways in which addressing stigma in primary care can help achieve the goal of eliminating HCV by 2030
  • Confidently apply effective communication techniques and tools to overcome stigma and optimise outcomes for patient with HCV infection

Accreditation

This program is accredited by the Australian College of Rural & Remote Medicine for 1 PDP hour of Educational activity.

Activity no. 24118

Cost of course:  
Free
# of credits: 1
Duration: 1.5 hr

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.